Form 4: Fractyl Health, Inc. Executive Acquires 250,000 Stock Options
SEC Filing Form 4
Adrian Kimber, Chief Commercial Officer of Fractyl Health, Inc., acquired 250,000 stock options on April 1, 2024.
Summary
- Adrian Kimber, the Chief Commercial Officer of Fractyl Health, Inc. (GUTS), filed a Form 4 on April 2, 2024, reporting a transaction.
- On April 1, 2024, Kimber acquired 250,000 stock options with an exercise price of $7.45.
- These options vest as to 25% on April 1, 2025, and the remaining 75% vest in 36 equal monthly installments thereafter, contingent upon continued service to Fractyl Health.
Sentiment
Score: 6
Explanation: The document itself is neutral, simply reporting a transaction. The sentiment is slightly positive as it indicates an executive's belief in the company's future, but it's not overwhelmingly positive.
Positives
- The acquisition of stock options by a key executive could signal confidence in the company's future performance.
Industry Context
Executive compensation packages often include stock options to align management's interests with those of shareholders, incentivizing them to increase the company's value.
Stakeholder Impact
- Shareholders may view the executive's stock option acquisition as a positive sign, aligning management's interests with their own.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of stock option acquisition. |
| 04/01/2025 | Date when 25% of the stock options vest. |
| 03/31/2034 | Expiration date of the stock options. |
| 04/02/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.